These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12795734)

  • 1. Physician and patient factors associated with ordering a colon evaluation after a positive fecal occult blood test.
    Turner B; Myers RE; Hyslop T; Hauck WW; Weinberg D; Brigham T; Grana J; Rothermel T; Schlackman N
    J Gen Intern Med; 2003 May; 18(5):357-63. PubMed ID: 12795734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physician intention to recommend complete diagnostic evaluation in colorectal cancer screening.
    Myers RE; Hyslop T; Gerrity M; Schlackman N; Hanchak N; Grana J; Turner BJ; Weinberg D; Hauck WW
    Cancer Epidemiol Biomarkers Prev; 1999 Jul; 8(7):587-93. PubMed ID: 10428195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete diagnostic evaluation in colorectal cancer screening: research design and baseline findings.
    Myers RE; Turner B; Weinberg D; Hauck WW; Hyslop T; Brigham T; Rothermel T; Grana J; Schlackman N
    Prev Med; 2001 Oct; 33(4):249-60. PubMed ID: 11570828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of complete diagnostic examination in clinical practice settings.
    Jimbo M; Meyer B; Hyslop T; Cocroft J; Turner BJ; Weinberg DS; Myers RE
    Cancer Detect Prev; 2006; 30(6):545-51. PubMed ID: 17113240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring complete diagnostic evaluation in colorectal cancer screening.
    Myers RE; Fishbein G; Hyslop T; Hauck WW; Kutch M; Grana JR; Schlackman N
    Cancer Detect Prev; 2001; 25(2):174-82. PubMed ID: 11341353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reasons patients with a positive fecal occult blood test result do not undergo complete diagnostic evaluation.
    Jimbo M; Myers RE; Meyer B; Hyslop T; Cocroft J; Turner BJ; Weinberg DS
    Ann Fam Med; 2009; 7(1):11-6. PubMed ID: 19139444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a physician-oriented intervention on follow-up in colorectal cancer screening.
    Myers RE; Turner B; Weinberg D; Hyslop T; Hauck WW; Brigham T; Rothermel T; Grana J; Schlackman N
    Prev Med; 2004 Apr; 38(4):375-81. PubMed ID: 15020170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result.
    Baig N; Myers RE; Turner BJ; Grana J; Rothermel T; Schlackman N; Weinberg DS
    Am J Gastroenterol; 2003 Sep; 98(9):2078-81. PubMed ID: 14499791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers to full colon evaluation for a positive fecal occult blood test.
    Fisher DA; Jeffreys A; Coffman CJ; Fasanella K
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1232-5. PubMed ID: 16775188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement in the diagnostic evaluation of a positive fecal occult blood test in an integrated health care organization.
    Miglioretti DL; Rutter CM; Bradford SC; Zauber AG; Kessler LG; Feuer EJ; Grossman DC
    Med Care; 2008 Sep; 46(9 Suppl 1):S91-6. PubMed ID: 18725839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of colorectal cancer screening in diverse primary care practices.
    Zimmerman RK; Nowalk MP; Tabbarah M; Grufferman S
    BMC Health Serv Res; 2006 Sep; 6():116. PubMed ID: 16970813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Family physicians' choices of and opinions on colorectal cancer screening modalities.
    Zettler M; Mollon B; da Silva V; Howe B; Speechley M; Vinden C
    Can Fam Physician; 2010 Sep; 56(9):e338-44. PubMed ID: 20841573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.
    Church TR; Yeazel MW; Jones RM; Kochevar LK; Watt GD; Mongin SJ; Cordes JE; Engelhard D
    J Natl Cancer Inst; 2004 May; 96(10):770-80. PubMed ID: 15150305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal cancer screening: a community case-control study of proctosigmoidoscopy, barium enema radiography, and fecal occult blood test efficacy.
    Scheitel SM; Ahlquist DA; Wollan PC; Hagen PT; Silverstein MD
    Mayo Clin Proc; 1999 Dec; 74(12):1207-13. PubMed ID: 10593348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A national survey of primary care physicians' methods for screening for fecal occult blood.
    Nadel MR; Shapiro JA; Klabunde CN; Seeff LC; Uhler R; Smith RA; Ransohoff DF
    Ann Intern Med; 2005 Jan; 142(2):86-94. PubMed ID: 15657156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient preferences for colorectal cancer screening.
    Leard LE; Savides TJ; Ganiats TG
    J Fam Pract; 1997 Sep; 45(3):211-8. PubMed ID: 9300000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is barium enema an adequate diagnostic test for the evaluation of patients with positive fecal occult blood?
    Ramos C; De Jesús-Caraballo J; Toro DH; Ojeda A; Martínez-Souss J; Dueño MI; Cruz-Correa M
    Bol Asoc Med P R; 2009; 101(2):23-8. PubMed ID: 19954097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of double-contrast barium enema in colorectal cancer screening based on fecal occult blood.
    Ciatto S; Castiglione G
    Tumori; 2002; 88(2):95-8. PubMed ID: 12088265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in the management of positive fecal occult blood tests.
    Rao SK; Schilling TF; Sequist TD
    J Gen Intern Med; 2009 Mar; 24(3):356-60. PubMed ID: 19130147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving colorectal cancer screening in family medicine: an Oklahoma Physicians Resource/Research Network (OKPRN) study.
    Scheid DC; Hamm RM; Ramakrishnan K; McCarthy LH; Mold JW;
    J Am Board Fam Med; 2013; 26(5):498-507. PubMed ID: 24004701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.